Agios Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.25B 40M 2025-06
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amgen USD 1.69B 4M 2025-06
Arrowhead Research USD 30.95M 3.06M 2025-06
Astellas Pharma JPY 197B 14.32B 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Bayer EUR 3.55B 162M 2025-06
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Daiichi Sankyo JPY 180.35B 27.86B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Exelixis USD 134.86M 2.32M 2025-07
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Incyte USD 331.02M 5.33M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Merck USD 2.63B 104M 2025-06
Moderna USD 230M 18M 2025-06
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.5B 368M 2024-12
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06


Agios Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.